Lineage Cell Therapeutics
LCTX
#8554
Rank
ยฃ0.12 B
Marketcap
ยฃ0.55
Share price
-3.53%
Change (1 day)
-36.47%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -ยฃ17.78 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are ยฃ8.71 Million. In 2023 the company made an earning of -ยฃ19.56 Million a decrease over its 2022 earnings that were of -ยฃ17.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ17.78 Million-9.11%
2023 -ยฃ19.56 Million9.83%
2022 -ยฃ17.81 Million-54.24%
2021 -ยฃ38.92 Million86.07%
2020 -ยฃ20.92 Million-31.97%
2019 -ยฃ30.74 Million-5.42%
2018 -ยฃ32.51 Million1.1%
2017 -ยฃ32.15 Million-31.06%
2016 -ยฃ46.63 Million-10.38%
2015 -ยฃ52.04 Million29.69%
2014 -ยฃ40.13 Million31.68%
2013 -ยฃ30.47 Million
2011 -ยฃ14.79 Million89.78%
2010 -ยฃ7.8 Million206.06%
2009 -ยฃ2.55 Million-0.58%
2008 -ยฃ2.57 Million164.89%
2007 -ยฃ0.97 Million-30.22%
2006 -ยฃ1.39 Million
2002 -ยฃ1.61 Million-41.04%
2001 -ยฃ2.73 Million-32.04%
2000 -ยฃ4.02 Million-11.85%
1999 -ยฃ4.56 Million
1997 -ยฃ2.93 Million12.12%
1996 -ยฃ2.61 Million106.25%
1995 -ยฃ1.27 Million-11.11%
1994 -ยฃ1.43 Million50%
1993 -ยฃ0.95 Million20%
1992 -ยฃ0.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.11 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA